Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)

Tina Korošec, Jure Ačimovič, Matej Seliškar, Darko Kocjan, Klementina Fon Tacer, Damjana Rozman, Uroš Urleb

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14α-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.

Original languageEnglish (US)
Pages (from-to)209-221
Number of pages13
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Lanosterol
Anticholesteremic Agents
Azoles
Biosynthesis
Sterols
Heme
Amines
Assays
Cholesterol
Derivatives
Hep G2 Cells
Structure-Activity Relationship
Hepatocellular Carcinoma
pyridine

Keywords

  • Cholesterol biosynthesis inhibitors
  • Cholesterol intermediates profile
  • Human lanosterol 14α-demethylase (CYP51) inhibitors
  • Pyridylethanolamines

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Korošec, T., Ačimovič, J., Seliškar, M., Kocjan, D., Tacer, K. F., Rozman, D., & Urleb, U. (2008). Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51). Bioorganic and Medicinal Chemistry, 16(1), 209-221. https://doi.org/10.1016/j.bmc.2007.10.001

Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51). / Korošec, Tina; Ačimovič, Jure; Seliškar, Matej; Kocjan, Darko; Tacer, Klementina Fon; Rozman, Damjana; Urleb, Uroš.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 1, 01.01.2008, p. 209-221.

Research output: Contribution to journalArticle

Korošec, T, Ačimovič, J, Seliškar, M, Kocjan, D, Tacer, KF, Rozman, D & Urleb, U 2008, 'Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)', Bioorganic and Medicinal Chemistry, vol. 16, no. 1, pp. 209-221. https://doi.org/10.1016/j.bmc.2007.10.001
Korošec, Tina ; Ačimovič, Jure ; Seliškar, Matej ; Kocjan, Darko ; Tacer, Klementina Fon ; Rozman, Damjana ; Urleb, Uroš. / Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51). In: Bioorganic and Medicinal Chemistry. 2008 ; Vol. 16, No. 1. pp. 209-221.
@article{0a0cbc290b87416ba8908fb529095ff8,
title = "Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)",
abstract = "Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14α-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.",
keywords = "Cholesterol biosynthesis inhibitors, Cholesterol intermediates profile, Human lanosterol 14α-demethylase (CYP51) inhibitors, Pyridylethanolamines",
author = "Tina Korošec and Jure Ačimovič and Matej Seliškar and Darko Kocjan and Tacer, {Klementina Fon} and Damjana Rozman and Uroš Urleb",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.bmc.2007.10.001",
language = "English (US)",
volume = "16",
pages = "209--221",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)

AU - Korošec, Tina

AU - Ačimovič, Jure

AU - Seliškar, Matej

AU - Kocjan, Darko

AU - Tacer, Klementina Fon

AU - Rozman, Damjana

AU - Urleb, Uroš

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14α-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.

AB - Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14α-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.

KW - Cholesterol biosynthesis inhibitors

KW - Cholesterol intermediates profile

KW - Human lanosterol 14α-demethylase (CYP51) inhibitors

KW - Pyridylethanolamines

UR - http://www.scopus.com/inward/record.url?scp=38049161752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049161752&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2007.10.001

DO - 10.1016/j.bmc.2007.10.001

M3 - Article

C2 - 17964172

AN - SCOPUS:38049161752

VL - 16

SP - 209

EP - 221

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 1

ER -